US Stock MarketDetailed Quotes
HLIT Harmonic
- 12.820
- +0.260+2.07%
Close Nov 29 13:00 ET
- 12.820
- 0.0000.00%
Post 17:01 ET
1.49BMarket Cap17.59P/E (TTM)
12.840High12.600Low465.83KVolume12.600Open12.560Pre Close5.96MTurnover0.41%Turnover Ratio17.81P/E (Static)116.53MShares15.46052wk High3.48P/B1.46BFloat Cap9.10052wk Low--Dividend TTM113.60MShs Float157.500Historical High--Div YieldTTM1.91%Amplitude1.010Historical Low12.786Avg Price1Lot Size
Harmonic Stock Forum
Sign in to post a comment
$Harmonic (HLIT.US)$ rose more than 10% after hours Monday after the video-solutions firm beat analyst estimates for its Q3 revenues and non-GAAP earnings.
HLIT added 11% to $16.45 shortly before 5 p.m. ET after reporting that net income came in at $0.26 per share, up from break-even in the same period last year and beating the $0.22 that analysts had reportedly expected.
Revenues totaled $195.8 million, rising 54% from the $127.2 million...
HLIT added 11% to $16.45 shortly before 5 p.m. ET after reporting that net income came in at $0.26 per share, up from break-even in the same period last year and beating the $0.22 that analysts had reportedly expected.
Revenues totaled $195.8 million, rising 54% from the $127.2 million...
11
3
$Harmonic (HLIT.US)$ pointless to buy any stock in runs for a few hours goes below .. because everyone doing calls or something nobody investing.. then a week later when price is nil the big players jump in... big stinky rag of a market
1
Harmonic's current share price is a bargain per the price multiple model. Despite a positive profit outlook, growth isn't fully factored into the price. A low beta suggests it may not reach industry peer level soon. Financial health should also be considered.
Harmonic Inc's high P/S ratio is justified by anticipated robust future revenue. Confidence in this revenue sustains the share price, assuming accurate analyst predictions.
1
$Harmonic (HLIT.US)$ looks bad.. for coming quarters?
U.S. stock futures were trading within a tight range during Monday's evening deals after major benchmark averages posted moderate gains as investors look toward a fresh deluge of quarterly earnings results throughout the week.
Yum China Holdings $Yum China (YUMC.US)$ fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected.
Harmonic $Harmonic (HLIT.US)$ shed 13.7% after report...
Yum China Holdings $Yum China (YUMC.US)$ fell 2.8% after the company reported Q2 EPS of $0.47 versus $0.46 expected, with revenues of $2.65 billion versus $2.72B expected.
Harmonic $Harmonic (HLIT.US)$ shed 13.7% after report...
4
$Harmonic (HLIT.US)$ $Occidental Petroleum (OXY.US)$ anyone knows harmonic will be up its 3q profit?
Upgrades
• $Marqeta (MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural (NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide (OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake (SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton (ETN.US)$ : Barclays Downgrades to Underweight from Eq...
• $Marqeta (MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural (NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide (OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake (SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton (ETN.US)$ : Barclays Downgrades to Underweight from Eq...
12
1
Gainers:
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
17
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Upgrades
• $Bank First (BFC.US)$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent (ETWO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $Harmonic (HLIT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess (MKTX.US)$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy (PBF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $Range Resources (RRC.US)$ : Piper S...
• $Bank First (BFC.US)$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent (ETWO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $Harmonic (HLIT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess (MKTX.US)$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy (PBF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $Range Resources (RRC.US)$ : Piper S...
9
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
章允量 :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
James 101542649 : good
Adrianlim90 : 1